The largest database of trusted experimental protocols

12 protocols using sars cov 2 ddpcr kit

1

SARS-CoV-2 Quantification via ddPCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
An aliquot of 5.5 μL from a dilution of the eluent (samples were diluted to be within the range required for ddPCR) was input into 22 μL reactions of the Bio-Rad SARS-CoV-2 ddPCR Kit (Cat. 12013743, BioRad Laboratories) for multiplex quantification of SARS-CoV-2 N1 and N2 targets, and human RNase P targets. Droplets were generated on a QX200 droplet generator (#1864002, Bio-Rad Laboratories) and measured using a QX200 Droplet Digital PCR System (#1864001, Bio-Rad Laboratories), with analysis using QuantaSoft Analysis Software.
+ Open protocol
+ Expand
2

SARS-CoV-2 Plasma Viral Load Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma viral load measurement was performed as previously described (7 (link)). Briefly, viral RNA was extracted from 100 µL or 200 µL of plasma using the QIAamp Viral Mini Kit (Qiagen) and used immediately in the Bio-Rad SARS-CoV-2 ddPCR kit (Bio-Rad). CDC Nucleocapsid gene primers were used. Data were analyzed using QuantaSoft 1.7 and QuantaSoft Analysis Pro 1.0 software. The reproducible limit of detection of the assay is 313 viral copies per mL of plasma (7 (link)).
+ Open protocol
+ Expand
3

SARS-CoV-2 RNA Detection in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Viral RNA was extracted from 1.0 mL EDTA plasma using QIAsymphony DSP Virus/Pathogen Midi Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. A total of 1.2 mL sample were loaded to the QiaSymphony Robot (Qiagen) and in the case sample volume was less than 1.2 mL, Nuclease-free water (Sigma-Aldrich) was added for adjustment. Extracted RNA was eluted in 60 µL. One-step RT-ddPCR was initiated immediately after RNA extraction using the Bio-Rad SARS-CoV-2 ddPCR kit (Bio-Rad, Hercules, CA, USA) according to manufacturer's specifications. All samples were spiked with non-human CPP1 as control of extraction [5] . For each sample extraction batch, a positive template control (COV019, Bio-Rad), and two negative controls (COV000, Bio-Rad and Nuclease-free water, Sigma-Aldrich) were included. ddPCR results were analyzed using the QX Manager standard edition (1.1.341, Bio-Rad) and the concentration of SARS CoV-2 RNA was calculated pr. mL plasma. A sample is considered positive for SARS-CoV-2 if the SARS-CoV-2 markers N1 and/ or N2 exhibit ≥2 positive droplets, as described by Bio-Rad.
+ Open protocol
+ Expand
4

Quantifying SARS-CoV-2 Transcripts in Whole Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Bio-Rad SARS-CoV-2 ddPCR Kit (FDA-cleared for COVID diagnosis from nasal swab RNA) was used to measure nucleocapsid transcripts (N1 and N2) of the SARS-CoV2 in Tempus whole blood RNA. cDNA synthesis and ddPCR was accomplished with a one-step RT-ddPCR mix (Bio Rad) added directly to the RNA. A mix of primers and FAM/HEX probes for N1, N2 and human RNase P (RP) was added (Bio Rad). After droplet generation, the thermal cycler reverse transcribed the RNA and then amplified the cDNA. Droplets were read using the Bio Rad QX200 and clusters were gated using the Bio Rad Quantasoft Analysis Pro software. RP was included as a control to confirm proper amplification and reading. Samples generating two or more N1+ or N2+ droplets were considered positive as specified by the manufacturer.
+ Open protocol
+ Expand
5

SARS-CoV-2 Detection by ddPCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Extracted TNA (100 ng) was used for SARS-CoV-2 detection and quantification by droplet digital PCR (ddPCR), by using the SARS-CoV-2 ddPCR Kit (Bio-Rad Laboratories, Milan, Italy). Briefly, three targets are analyzed in each sample by FAM and HEX labeled probes, targeting SARS-CoV-2 N1 and N2 genes, and human RPP30 gene, this last was used as a control and to normalize the virus counts. The assay sensitivity was between 0.260 copies/μl to 0.351 copies/μl, respectively, for the genetic markers N1 and N2.
+ Open protocol
+ Expand
6

SARS-CoV-2 RNA and IgG Profiling in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was extracted from 100 µl of plasma using an automated system, eMAG® from bioMérieux® (Marcy l'Etoile, France). Detection and quantification of SARS-CoV-2 RNA was performed in five µl of the eluted solution using the Bio-Rad SARS-CoV-2 ddPCR kit according to manufacturer’s specifications on a QX-200 droplet digital PCR platform from the same provider. This PCR targets the N1 and N2 regions of the viral nucleoprotein gene and also the human ribonuclease (RNase) P gene using the primers and probes sets detailed in the CDC 2019 Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel [22 ]. Samples were considered positive for SARS-CoV-2 when N1 and/or N2 presented values ≥ 0.1 copies/µL in a given reaction. RNase P gene was considered positive when it presented values ≥ 0.2 copies/µL, following manufacturer`s indications. The test was only considered valid when RNase P gene was positive. Final results were given in copies of cDNA / mL of plasma. IgG specific for the nucleocapsid protein of SARS–CoV-2 was detected in 150 µl of plasma using the Abbott Architect SARS-CoV-2 IgG Assay (Illinois, USA). Viral RNA and SARS-CoV-2 IgG were profiled in the same plasma sample.
+ Open protocol
+ Expand
7

SARS-CoV-2 Detection in Autopsy Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNAlater (Invitrogen)-preserved autopsy tissues were homogenized and processed as previously described (6 (link)). Total RNA was extracted using RNeasy Mini, RNeasy Fibrous Tissue Mini, and RNeasy Lipid Tissue Mini Kits (Qiagen). The QX200 AutoDG Droplet Digital PCR (ddPCR) System (Bio-Rad) was used to detect SARS-CoV-2 RNA using the SARS-CoV-2 ddPCR Kit (Bio-Rad) (6 (link)). For samples to be considered positive for SARS-CoV-2 nucleocapsid 1 (N1) or 2 (N2) genes, the manufacturer’s limit of detection of >/= 0.1 copies/µl final ddPCR reaction and 2 positive droplets per well was required.
+ Open protocol
+ Expand
8

RNA Extraction and SARS-CoV-2 Detection by ddPCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from oropharyngeal and nasopharyngeal swabs preserved in viral transport media and plasma using the QIAamp Viral RNA Mini Kit (Qiagen, Germantown, MD, USA) according to the manufacturer’s protocols. Total RNA was extracted from tracheal aspirates digested 1:1 with Remel Sputasol (ThermoFisher Scientific, Waltham, MA) according to manufacturer’s instructions, and 200 μL of digested tracheal aspirate were added to 1 mL QIAzol (Qiagen). A chloroform extraction was performed, and the aqueous layer was added to the RNeasy Mini Kit (Qiagen) to extract total RNA using the manufacturer’s protocol for animal cells and tissues. The NanoDrop ND-1000 Spectrophotometer (Thermo Scientific, Waltham, MA, USA) was used to quantify RNA concentrations from tracheal aspirates. RNA extracted via the QIAamp Viral RNA Mini Kit was not quantified via NanoDrop due to the presence of carrier RNA. The QX200 AutoDG Droplet Digital PCR System (Bio-Rad, Hercules, CA, USA) was used to detect and quantify SARS-CoV-2 RNA using the SARS-CoV-2 ddPCR Kit (Bio-Rad) as previously described (14 )
+ Open protocol
+ Expand
9

Simultaneous SARS-CoV-2 Nucleocapsid Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Simultaneous quantification of 2 SARS-CoV-2 nucleocapsid (N) target sequences (N1 and N2) and human RNase P-encoding (RPP30) sequence was performed using the Bio-Rad SARS-CoV-2 ddPCR Kit with the QX200 AutoDG Droplet Digital PCR System (QX200 AutoDG System; Bio-Rad Laboratories, Hercules, CA). Reaction mixtures of 22 µL each were prepared as follows: 5.5 µL of 4x One Step-RT-ddPCR Supermix, 2.2 µL of reverse transcriptase, 1.1 µL of dithiothreitol, 1.1 µL of the 20 × 2019-nCoV CDC ddPCR triplex probe TaqMan assay, and 12 uL of TNA. Of this 22-uL reacture mixture, 20 uL were loaded onto the instrument for testing. Final concentrations of primers and probes were 900 and 250 nmol/L, respectively. The PCR plates were placed on the QX200 AutoDG, followed by RT-ddPCR amplification as follows: 25 °C for 3 min and 50 °C for 60 min, followed by the PCR steps: 95 °C for 10 min, then 40 cycles of denaturation at 95 °C for 30 s and annealing/extension at 55 °C for 1 min, and a final enzyme deactivation at 98 °C for 10 min. Targets in the droplets were counted by the QX200 Droplet Reader, and signal data were analyzed using QuantaSoft Analysis Pro-software version 1.0.596 (Bio-Rad Laboratories, Inc., Hercules, CA). Preparation of amplification plate, amplification, detection, and data analysis required 4.5 hr and 7.5 hr for 24- and 96-sample assay runs, respectively.
+ Open protocol
+ Expand
10

SARS-CoV-2 Viral Load Quantification via ddPCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
After extracted RNA samples were tested for RT-qPCR, they were stored at -80°C until ddPCR testing. The assay uses the QX200 AutoDG Droplet Digital PCR System (Bio-Rad Laboratories, Hercules, CA) following the Bio-Rad SARS-CoV-2 ddPCR Kit EUA Instructions for Use. Viral load measured in RNA extract was corrected for input and output extraction volumes and 10-fold dilution into assay-specific extraction buffer to determine viral load in residual samples applied to Ag RDT as described previously [22] (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!